Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824613 | Clinical Therapeutics | 2015 | 16 Pages |
Abstract
Use of biosimilar G-CSFs for supportive cancer care could yield potential cost savings and improve patient access to antineoplastic therapy in a budget neutral way-a financial effect with an ethical perspective.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Diana MS, Tri Murti PhD, Ahmed PharmD, Karen PhD, Ivo PhD,